Key statistics
52-week range
| Open | 0.175 |
|---|---|
| High | 0.18 |
| Low | 0.16 |
| Bid | 0.16 |
| Offer | 0.18 |
| Previous close | 0.17 |
| Average volume | 55.79k |
|---|---|
| Shares outstanding | 200.05m |
| Free float | 170.69m |
| P/E (TTM) | -- |
| Market cap | 33.70m CAD |
| EPS (TTM) | -0.0387 CAD |
Data delayed at least 15 minutes, as of Feb 10 2026 20:51 GMT.
More ▼
- UPDATE OF THE TRANSACTION ANNOUNCED ON NOVEMBER 25, 2025, FOR THE ACQUISITION OF THE MINORITY INTEREST IN THE SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.
- KDA GROUP ANNOUNCES A COLLABORATION TO INTEGRATE NEW CLINICAL ALERTS INTO THE MEDHERIZE PLATFORM TO SUPPORT THE ADOPTION OF NEXT-GENERATION SEQUENCING FOR BREAST CANCER PATIENTS
- KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUÉBEC-UNIVERSITÉ LAVAL FOR THE DEPLOYMENT OF MEDHERIZE
- KDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT OF ORAL ANTICANCER THERAPIES
- KDA GROUP ANNOUNCES AGREEMENT TO ACQUIRE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.
- KDA GROUP OPENS A U.S. SUBSIDIARY AND ACCELERATES THE GROWTH OF ITS MEDHERIZE SOLUTION
More ▼
